Labcorp Holdings Inc. LH
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.81B | 3.73B | 3.54B | 3.52B | 3.56B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.81B | 3.73B | 3.54B | 3.52B | 3.56B |
| Cost of Revenue | 2.70B | 2.62B | 2.52B | 2.52B | 2.54B |
| Gross Profit | 1.11B | 1.11B | 1.01B | 993.20M | 1.03B |
| SG&A Expenses | 611.40M | 577.20M | 551.00M | 549.70M | 553.10M |
| Depreciation & Amortization | 78.70M | 78.10M | 75.60M | 72.60M | 69.50M |
| Other Operating Expenses | 2.50M | -- | -- | -- | -- |
| Total Operating Expenses | 3.39B | 3.27B | 3.15B | 3.14B | 3.16B |
| Operating Income | 415.50M | 456.70M | 387.20M | 370.90M | 402.50M |
| Income Before Tax | 328.00M | 386.40M | 319.70M | 190.60M | 337.00M |
| Income Tax Expenses | 64.90M | 87.30M | 41.70M | 25.70M | 75.50M |
| Earnings from Continuing Operations | 263.10M | 299.10M | 278.00M | 164.90M | 261.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -300.00K | -400.00K | -200.00K | -200.00K | -400.00K |
| Net Income | 262.80M | 298.70M | 277.80M | 164.70M | 261.10M |
| EBIT | 415.50M | 456.70M | 387.20M | 370.90M | 402.50M |
| EBITDA | 598.50M | 635.70M | 560.50M | 549.40M | 573.50M |
| EPS Basic | 3.24 | 3.66 | 3.38 | 2.00 | 3.14 |
| Normalized Basic EPS | 2.63 | 2.99 | 2.53 | 2.39 | 2.57 |
| EPS Diluted | 3.22 | 3.64 | 3.35 | 1.97 | 3.12 |
| Normalized Diluted EPS | 2.61 | 2.98 | 2.51 | 2.37 | 2.56 |
| Average Basic Shares Outstanding | 81.10M | 81.70M | 82.30M | 82.50M | 83.10M |
| Average Diluted Shares Outstanding | 81.60M | 82.00M | 82.90M | 83.20M | 83.70M |
| Dividend Per Share | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 |
| Payout Ratio | 22.15% | 19.65% | 22.03% | 36.00% | 22.94% |